Newport Beach-based Evolus, Inc., a prominent player in the performance beauty sector, specializes in providing cutting-edge medical aesthetics solutions to patients and physicians all across the United States. At the forefront of their product lineup is Jeuveau, a 900 kilodalton purified botulinum toxin type A formulation that promises temporary improvement of moderate to severe glabellar lines in adults. Geared towards the self-pay aesthetic healthcare market, Evolus has been making waves since its inception in 2012, with its innovative approach to the industry.
Evolus's ticker is EOLS
The company's shares trade on the NASDAQ stock exchange
They are based in Newport Beach, California
There are 51-200 employees working at Evolus
It is evolus.com/our-team
Evolus is in the Healthcare sector
Evolus is in the Drug Manufacturers - Other industry
The following five companies are Evolus's industry peers: